PubRank

Matthias J Bahr

Author PubWeight™ 43.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology 2011 2.49
2 Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009 2.26
3 Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. Hepatology 2007 1.97
4 Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 2009 1.73
5 Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol 2008 1.59
6 Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004 1.55
7 Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 2009 1.29
8 Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002 1.27
9 Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). Dig Liver Dis 2011 1.27
10 Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology 2008 1.20
11 The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol 2013 1.20
12 Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010 1.18
13 Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 2004 1.12
14 Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci (Lond) 2003 1.03
15 Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 2007 0.96
16 Prometheus--a new extracorporeal system for the treatment of liver failure. J Hepatol 2003 0.95
17 Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 2004 0.94
18 Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study. Dig Liver Dis 2011 0.93
19 Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 2008 0.91
20 Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy. Gastroenterol Res Pract 2009 0.91
21 Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications. J Hepatol 2008 0.90
22 Noninvasive diagnosis of fibrosis in chronic liver disease. Expert Rev Mol Diagn 2004 0.90
23 Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT). Hepatology 2003 0.89
24 Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases. J Hepatol 2008 0.89
25 A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation. Liver Transpl 2006 0.84
26 Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice. J Lipid Res 2013 0.82
27 Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography. PLoS One 2012 0.82
28 Membranous Budd-Chiari syndrome in Caucasians. Scand J Gastroenterol 2010 0.81
29 Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones. Clin Transplant 2002 0.81
30 Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation. Liver Transpl 2004 0.79
31 Gilbert's syndrome and antiviral therapy of hepatitis C. Ann Hepatol 2009 0.79
32 HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration. J Hepatol 2007 0.78
33 Changing faces-natural course and treatment of hepatitis C after liver transplantation. J Hepatol 2004 0.78
34 Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation. Transpl Int 2002 0.77
35 [New devices in liver replacement therapy]. Med Klin (Munich) 2003 0.76
36 Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation. Transplantation 2003 0.76
37 An apoptosis biomarker for prediction of nonalcoholic steatohepatitis. Hepatology 2009 0.76
38 Regional and transient ischemia/reperfusion injury in the liver improves therapeutic efficacy of allogeneic intraportal hepatocyte transplantation in low-density lipoprotein receptor deficient Watanabe rabbits. J Hepatol 2004 0.76
39 Discussion on the association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002 0.75
40 Liver stiffness after meal intake at different stages of fibrotic evolution. Hepatology 2013 0.75
41 Mycosis fungoides with involvement of the larynx after liver transplantation in an adult. Am J Gastroenterol 2010 0.75
42 Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection--role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system. Crit Care Med 2009 0.75